Ventricular overdrive pacing-induced preconditioning and no-flow ischemia-induced preconditioning in isolated working rat hearts

J Cardiovasc Pharmacol. 1995 Jan;25(1):97-104. doi: 10.1097/00005344-199501000-00016.

Abstract

To examine preconditioning induced by short periods of ventricular overdrive pacing (VOP) as compared with that induced by no-flow ischemia, we subjected isolated working rat heart to 10-min coronary artery occlusion (test ischemia) followed by 3-min reperfusion after three intermittent periods of VOP (10 Hz) or 5-min no-flow ischemia, respectively. In the nonpreconditioned group, coronary occlusion decreased aortic flow (AF) from 46.6 +/- 2.4 to 13.7 +/- 1.7 ml/min and increased left ventricular end-diastolic pressure (LVEDP) from 0.53 +/- 0.05 to 2.02 +/- 0.07 kPa. Preconditioning by VOP or no-flow ischemia significantly increased AF to 25.1 +/- 2.3 ml/min (p < 0.001) and to 27.3 +/- 1.4 ml/min (p < 0.001) and decreased LVEDP to 1.38 +/- 0.1 kPa (p < 0.001) and to 1.65 +/- 0.05 kPa (p < 0.05), respectively, after test ischemia. Glibenclamide 10(-7) M which blocked the anti-ischemic effect of the ATP-sensitive K(+)-channel (KATP) opener cromakalim, inhibited VOP-induced protection (AF 20.3 +/- 2.3 ml/min; LVEDP 1.82 +/- 0.15 kPa), but did not affect no-flow ischemia-induced preconditioning [AF 26.6 +/- 2.4 ml/min (p < 0.001), LVEDP 1.60 +/- 0.07 kPa (p < 0.01)]. VOP and no-flow ischemia precondition heart, however their cardioprotective mechanisms may be different in terms of KATP activation in rats.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzopyrans / pharmacology
  • Blood Pressure / drug effects
  • Blood Pressure / physiology
  • Cardiac Pacing, Artificial*
  • Coronary Circulation / drug effects
  • Coronary Circulation / physiology
  • Cromakalim
  • Disease Models, Animal
  • Glyburide / pharmacology
  • Heart / drug effects
  • In Vitro Techniques
  • Male
  • Myocardial Ischemia / pathology*
  • Myocardial Ischemia / physiopathology
  • Myocardial Ischemia / prevention & control
  • Myocardial Reperfusion
  • Myocardial Reperfusion Injury / pathology
  • Myocardial Reperfusion Injury / prevention & control
  • Potassium Channels / drug effects*
  • Pyrroles / pharmacology
  • Rats
  • Rats, Wistar
  • Vasodilator Agents / pharmacology

Substances

  • Benzopyrans
  • Potassium Channels
  • Pyrroles
  • Vasodilator Agents
  • Cromakalim
  • Glyburide